arrow
B

Bhavisha A. Patel

national institutes of health
H指数:27
被引数:3,944

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Endotheliopathy and VWF-ADAMTS13 axis dysfunction in VEXAS thrombogenicity

血管内皮病和VWF-ADAMTS13轴功能障碍在VEXAS血栓形成中的作用

Blood
IF23.1
2026-10-020
OAAI
American College of Rheumatology Guidance Statement for Diagnosis and Management of VEXAS Developed by the International VEXAS Working Group Expert Panel

美国风湿病学会关于VEXAS诊断与管理的指南声明,由国际VEXAS工作组专家委员会制定

2025-08-110
OAAI
In depth transcriptomic profiling defines a landscape of dysfunctional immune responses in patients with VEXAS syndrome

深度转录组分析定义了VEXAS综合征患者中失调的免疫反应图谱

2025-05-200
OA
Complement Mediated Immune Activation in HLA Class I Alloimmunized Immune Aplastic Anemia Imputed from Single Cell Analysis of Peripheral Cell Subsets

HLA Class I 同种免疫激活的免疫再生障碍性贫血中,通过外周细胞亚群的单细胞分析推断的补体介导的免疫激活

BLOOD
IF23.1
2024-11-050
PRE
DNMT3A Mutant Clonal Hematopoiesis in Vexas Syndrome Epigenetically Potentiates IL-13 and IL-15 Inflammatory Pathways and Is Associated with Increased Mortality

DNMT3A突变克隆性造血在Vexas综合征中表观遗传学上增强了IL-13和IL-15炎症通路,并与死亡率增加相关。

BLOOD
IF23.1
2024-11-050
PRE
Opportunistic Infections, Mortality Risk, and Prevention Strategies in Patients With Vacuoles, E1 Enzyme, X-Linked, Autoinflammatory, Somatic (VEXAS) Syndrome
2024-07-234
OA
Immune-monitoring of myelodysplastic neoplasms: Recommendations from the i4MDS consortium
2024-05-151
OAAI
Granulocyte transfusions in severe aplastic anemia
2023-12-072
OAAI